Results 201 to 210 of about 4,295 (215)

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy

Annals of Oncology, 2009
exaly  

Antineoplastics/methylprednisolone/netupitant/palonosetron

Reactions Weekly, 2020
openaire   +1 more source

Efficacy, safety and pharmacokinetics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy:a dose-ranging clinical study

Annals of Oncology, 2004
exaly  

Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy

Annals of Oncology, 2010
exaly  

Antineoplastics/doxorubicin/palonosetron

Reactions Weekly, 2017
openaire   +1 more source

Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation

Annals of Oncology, 2011
exaly  

Palonosetron (r)

2011
openaire   +1 more source

Pharmacokinetic and Safety Evaluation of Palonosetron, a 5-Hydroxytryptamine-3 Receptor Antagonist, in U.S. and Japanese Healthy Subjects

Journal of Clinical Pharmacology, 2004
exaly  

Aprepitant/dexamethasone/diphenhydramine/palonosetron

Reactions Weekly, 2013
openaire   +1 more source

Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anaesthesia

British Journal of Anaesthesia, 2014
exaly